Literature DB >> 33305715

Carbapenem-resistant Enterobacteriaceae epidemiology in Veterans' Affairs medical centers varies by facility characteristics.

Marissa S Wirth1, Margaret A Fitzpatrick1,2, Katie J Suda3,4, Geneva M Wilson1, Swetha Ramanathan1, Martin E Evans5, Makoto M Jones6,7, Christopher D Pfeiffer8,9, Charlesnika T Evans1,10.   

Abstract

This is an epidemiological study of carbapenem-resistant Enterobacteriaceae (CRE) in Veterans' Affairs medical centers (VAMCs). In 2017, almost 75% of VAMCs had at least 1 CRE case. We observed substantial geographic variability, with more cases in urban, complex facilities. This supports the benefit of tailoring infection control strategies to facility characteristics.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33305715      PMCID： PMC8628350          DOI： 10.1017/ice.2020.1323

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   6.520


  8 in total

1.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.

Authors:  Yanling Xu; Bing Gu; Mao Huang; Haiyan Liu; Ting Xu; Wenying Xia; Tong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States.

Authors:  Vikas Gupta; Gang Ye; Melanie Olesky; Kenneth Lawrence; John Murray; Kalvin Yu
Journal:  Int J Infect Dis       Date:  2019-06-20       Impact factor: 3.623

Review 3.  Travel and the Spread of Drug-Resistant Bacteria.

Authors:  Kevin L Schwartz; Shaun K Morris
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Spread of Carbapenem-Resistant Enterobacteriaceae Among Illinois Healthcare Facilities: The Role of Patient Sharing.

Authors:  Michael J Ray; Michael Y Lin; Robert A Weinstein; William E Trick
Journal:  Clin Infect Dis       Date:  2016-08-02       Impact factor: 9.079

Review 5.  Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.

Authors:  Ana M Kelly; Barun Mathema; Elaine L Larson
Journal:  Int J Antimicrob Agents       Date:  2017-06-21       Impact factor: 5.283

6.  Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Authors:  Gopi Patel; Shirish Huprikar; Stephanie H Factor; Stephen G Jenkins; David P Calfee
Journal:  Infect Control Hosp Epidemiol       Date:  2008-12       Impact factor: 3.254

7.  Vital signs: carbapenem-resistant Enterobacteriaceae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-08       Impact factor: 17.586

8.  Carbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014.

Authors:  Sun O Park; Jianfang Liu; E Yoko Furuya; Elaine L Larson
Journal:  Open Forum Infect Dis       Date:  2016-12-02       Impact factor: 3.835
  8 in total
  1 in total

1.  Genomic Epidemiology of Carbapenemase-Producing and Colistin-Resistant Enterobacteriaceae among Sepsis Patients in Ethiopia: a Whole-Genome Analysis.

Authors:  Melese Hailu Legese; Daniel Asrat; Adane Mihret; Badrul Hasan; Amaha Mekasha; Abraham Aseffa; Göte Swedberg
Journal:  Antimicrob Agents Chemother       Date:  2022-07-25       Impact factor: 5.938
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.